Vanguard Personalized Indexing Management
NTLA icon

Vanguard Personalized Indexing Management’s Intellia Therapeutics NTLA Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio NTLA Stock Details NTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$193K Buy
11,434
+189
+2% +$2.65K ﹤0.01% 1940
2026
Q1 		$144K Buy
+11,245
New +$143K ﹤0.01% 1890
2025
Q4 		– Sell
-10,995
Closed -$190K – 2041
2025
Q3 		$190K Buy
10,995
+718
+7% +$8.84K ﹤0.01% 1721
2025
Q2 		$96.4K Sell
10,277
-931
-8% -$7.64K ﹤0.01% 1746
2025
Q1 		$79.7K Buy
+11,208
New +$113K ﹤0.01% 1641
2024
Q2 		– Sell
-8,944
Closed -$246K – 1728
2024
Q1 		$246K Buy
8,944
+2,197
+33% +$61K 0.01% 1360
2023
Q4 		$206K Buy
+6,747
New +$194K 0.01% 1405
2023
Q3 		– Sell
-5,854
Closed -$239K – 1535
2023
Q2 		$239K Sell
5,854
-972
-14% -$39.4K 0.01% 1249
2023
Q1 		$254K Buy
+6,826
New +$268K 0.01% 1199
2022
Q4 		– Sell
-6,546
Closed -$366K – 1311
2022
Q3 		$366K Buy
6,546
+274
+4% +$17K 0.02% 894
2022
Q2 		$325K Buy
6,272
+2,424
+63% +$123K 0.02% 959
2022
Q1 		$280K Buy
3,848
+1,375
+56% +$116K 0.01% 1017
2021
Q4 		$292K Sell
2,473
-1,186
-32% -$149K 0.02% 872
2021
Q3 		$491K Buy
+3,659
New +$554K 0.04% 523

Other funds holding NTLA

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
RP
Regeneron Pharmaceuticals Tarrytown, New York $177M AUM 9.82% 1-Year Est. Return

Vanguard Personalized Indexing Management's NTLA Position: Q2 2026 in Review

Vanguard Personalized Indexing Management increased its Intellia Therapeutics (NTLA) stake by 1.7% in Q2 2026, buying an estimated $2.65K and bringing the position to 11,434 shares worth $193K. The position accounts for ﹤0.01% of the portfolio, ranked #1940.

Vanguard Personalized Indexing Management first reported a position in NTLA in Q3 2021 and has held it in 14 quarters since. The position peaked at $491K in Q3 2021. 328 funds tracked by Wall St. Rank hold NTLA as of Q2 2026.

  • Vanguard Personalized Indexing Management held 11,434 shares of Intellia Therapeutics worth $193K as of Q2 2026.
  • Vanguard Personalized Indexing Management bought 189 Intellia Therapeutics shares in Q2 2026, an estimated $2.65K.
  • Intellia Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #1940 holding.
  • Vanguard Personalized Indexing Management first reported a position in Intellia Therapeutics in Q3 2021 and has held it in 14 quarters since.
  • Vanguard Personalized Indexing Management's Intellia Therapeutics position peaked at $491K in Q3 2021.
  • 328 funds tracked by Wall St. Rank held Intellia Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.